Oct 6, 2022
Michael Gray is the CEO of Actus Analytical, Inc., which develops spectroscopy solutions for public safety compliance, illicit drug detection, agricultural productivity, and other applications.
Michael and his wife Nancy founded The Actus Foundation, a 501(c)(3) charitable organization, in 2018. The Actus Foundation advocates for solutions to treating the entirety of the overdose epidemic problem in America, including the largely forgotten constituency of intermittent users. He founded, with partner Ed Kobilis in 2019, the Fentanyl Awareness Coalition - a coalition of tens of thousands of advocates in the US.
Michael is a popular speaker, offering unique analyses and suggestions for creative solutions to a new problem, i.e., an old problem with a recently altered paradigm. Michael walks participants through the murky world of the drug problem clarifying the threat and dispelling myths.
The Actus Foundation also advocates for the mentally ill, striving to deliver the message that mental illness is a disease the entire family suffers, and suffers in isolation; there are no well-worn paths to solutions available to those in chronic states of mental illness. For all our success in medical science – diagnostic practices, treatment/care and patient advocacy – our nation has left behavioral science in the stone age. Our practice of psychiatric care – diagnostic practices, treatment/care and patient advocacy – is the ugly stepchild hidden in the attic as the country proudly displays her medical science wonders to the world.
In addition to advocacy, Mr. Gray is offering his 35 years of professional expertise in the world of scientific instrumentation as another element of his work on behalf of the victims of overdose. As the Interdict Law and other legislative activity considers nascent technological advances in the ability to detect illicit drugs at the street level, Michael adds his professional expertise to that debate. With experience in the areas of Infrared Spectroscopy and Mass Spectrometry, Michael is participating in the development and deployment of portable testing for narcotics, at the field level, as a means of confirming suspected illegal substances and protecting First Responders.